Key players in Immunoglobulin Therapy
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | CSL Behring | — | 231 reports |
| 2 |  Takeda Pharmaceutical Company Ltd |
takeda.com (opens in a new tab) | 660 reports |
| 3 | Grifols | — | 132 reports |
| 4 |  Octapharma |
octapharma.com (opens in a new tab) | 99 reports |
| 5 |  Kedrion Biopharma |
kedrion.com (opens in a new tab) | 99 reports |
Also active in Immunoglobulin Therapy
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
| Company | Where public records show them |
|---|---|
 AstraZeneca |
|
 Novartis AG |
|
 GSK PLC |
|
 Regeneron Pharmaceuticals |
|
| Sichuan Baili Pharmaceutical Co., Ltd. |
|
| Viela Bio | |
 Johnson & Johnson |
|
 Otsuka Holdings Co Ltd |
|
| Shanghai Henlius Biotech |
|
| Vera Therapeutics | |
| BioNTech |
|
| Chemo Research SL |
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.
Top trial sponsors in Immunoglobulin Therapy
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
- AstraZeneca 70 active trials on ClinicalTrials.gov (opens in a new tab)
- Regeneron Pharmaceuticals 48 active trials on ClinicalTrials.gov (opens in a new tab)
- Sichuan Baili Pharmaceutical Co., Ltd. 38 active trials on ClinicalTrials.gov (opens in a new tab)
- Johnson & Johnson 28 active trials on ClinicalTrials.gov (opens in a new tab)
- Novartis AG 20 active trials on ClinicalTrials.gov (opens in a new tab)
- Shanghai Henlius Biotech 18 active trials on ClinicalTrials.gov (opens in a new tab)
- BioNTech 18 active trials on ClinicalTrials.gov (opens in a new tab)
- GSK PLC 17 active trials on ClinicalTrials.gov (opens in a new tab)
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Immunoglobulin Therapy reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Immunoglobulin Therapy report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.